Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1INDIV 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 4Lipoma 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Rectal Neoplasms 1Osteosarcoma 1Neutropenia 1Neoplasm Metastasis 1Multiple Myeloma 1Lung Neoplasms 1Liver Neoplasms 1Esophageal Neoplasms 1Cancer Cachexia 1Breast Neoplasms 1Barrett Esophagus 1Anemia 1

Interventions

macimorelin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × INDIV × Cancer Cachexia × Clear all
NCT01614990 2024-03-20

Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia

Garcia, Jose M., MD, PhD

Phase 2 Completed
15 enrolled 35 charts

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡